CN105879001A - 一种治疗“闭证”型中风的药物组合物 - Google Patents
一种治疗“闭证”型中风的药物组合物 Download PDFInfo
- Publication number
- CN105879001A CN105879001A CN201610474229.8A CN201610474229A CN105879001A CN 105879001 A CN105879001 A CN 105879001A CN 201610474229 A CN201610474229 A CN 201610474229A CN 105879001 A CN105879001 A CN 105879001A
- Authority
- CN
- China
- Prior art keywords
- parts
- pharmaceutical composition
- radix
- stroke
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 208000011580 syndromic disease Diseases 0.000 title claims abstract description 41
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 32
- 239000003814 drug Substances 0.000 claims abstract description 31
- 210000000582 semen Anatomy 0.000 claims abstract description 28
- 239000000284 extract Substances 0.000 claims abstract description 25
- 238000002360 preparation method Methods 0.000 claims abstract description 22
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 16
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 16
- 235000008434 ginseng Nutrition 0.000 claims abstract description 16
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 14
- 235000000126 Styrax benzoin Nutrition 0.000 claims abstract description 13
- 208000006011 Stroke Diseases 0.000 claims description 70
- 206010008190 Cerebrovascular accident Diseases 0.000 claims description 38
- 239000000843 powder Substances 0.000 claims description 26
- 241000208340 Araliaceae Species 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 15
- 235000015511 Liquidambar orientalis Nutrition 0.000 claims description 12
- 241000736148 Styrax Species 0.000 claims description 12
- 239000004870 Styrax Substances 0.000 claims description 12
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 239000007921 spray Substances 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 7
- -1 Calculus Bovis Substances 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 239000006199 nebulizer Substances 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 4
- 239000004575 stone Substances 0.000 claims description 4
- 239000006071 cream Substances 0.000 claims description 3
- 239000000835 fiber Substances 0.000 claims description 2
- 238000005469 granulation Methods 0.000 claims 2
- 230000003179 granulation Effects 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 1
- 239000000890 drug combination Substances 0.000 claims 1
- 239000003643 water by type Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 6
- 230000008901 benefit Effects 0.000 abstract description 3
- ISAOCJYIOMOJEB-UHFFFAOYSA-N benzoin Chemical compound C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 abstract 2
- 235000019382 gum benzoic Nutrition 0.000 abstract 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 241000544682 Acorus tatarinowii Species 0.000 abstract 1
- 244000144725 Amygdalus communis Species 0.000 abstract 1
- 235000011437 Amygdalus communis Nutrition 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000218671 Ephedra Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 244000028419 Styrax benzoin Species 0.000 abstract 1
- 244000303379 Styrax officinalis Species 0.000 abstract 1
- 235000001361 Styrax officinalis Nutrition 0.000 abstract 1
- 235000008411 Sumatra benzointree Nutrition 0.000 abstract 1
- 235000020224 almond Nutrition 0.000 abstract 1
- 229960002130 benzoin Drugs 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 229910052602 gypsum Inorganic materials 0.000 abstract 1
- 239000010440 gypsum Substances 0.000 abstract 1
- 230000007721 medicinal effect Effects 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 6
- 231100000111 LD50 Toxicity 0.000 description 5
- 241000283690 Bos taurus Species 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 238000001802 infusion Methods 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 231100000682 maximum tolerated dose Toxicity 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 230000002747 voluntary effect Effects 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 206010012373 Depressed level of consciousness Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 238000011887 Necropsy Methods 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 239000008896 Opium Substances 0.000 description 1
- 208000004224 Opium Dependence Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 201000007201 aphasia Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000015263 low fat diet Nutrition 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229960001027 opium Drugs 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 238000005453 pelletization Methods 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 235000021147 sweet food Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
- A61K35/10—Peat; Amber; Turf; Humus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/413—Gall bladder; Bile
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Nutrition Science (AREA)
- Neurosurgery (AREA)
- Inorganic Chemistry (AREA)
- Physiology (AREA)
- Marine Sciences & Fisheries (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开的一种治疗“闭证”型中风的中药组合物,人参8~10份、当归2~3份、熟地2~3份、甘草10~12份、桂枝8~10份、麻黄提取物8~10份、石膏0.1~0.3份、桃仁4~5份、杏仁4~5份、黄连4~5份、黄芩4~5份、大枣1~3份、干姜1~3份、牛黄4~5份、苏合香1~3份、安息香1~3份、牛角4~5份、龙骨1~3份、牡蛎4~5份、冰片0.1~0.3份、石菖蒲1~3份、琥珀0.1~0.3份;本发明又公开了一种治疗“闭证”型中风的中药组合物的制备方法;本发明所采取的处方精简,药力强见效快,综合现代制药方式,缩短了制备时间,使药效更加专一地对“闭证”型中风起作用。
Description
技术领域
本发明涉及中药领域,尤其涉及一种治疗“闭证”型中风的中药组合物。
背景技术
中风因发病急骤,症见多端,病情变化迅速,与风之善行数变特点相似,故名中风、卒中。本病常留有后遗症,发病年龄也趋向年轻化,因此,是威胁人类生命和生活质量的重大疾患。
中医认为中风为本虚标实之证,在本为阴阳偏胜,气机逆乱;在标为风火相煽,痰浊壅塞,瘀血内阻。常见的病因有忧思恼怒,饮酒无度,或恣食肥甘,纵欲劳累,或起居不慎等。中风有“闭证”与“脱证”之分,闭脱之证,皆是真阳衰损的“阴盛阳虚”证候。因脑溢血引起的中风是由于阳气上冲,聚于脑部,中枢神经就会受到比平日多几倍的刺激,由于大脑处于极度兴奋的状态,便有抽筋、痉挛神志不清、不省人事的病状,不论是“闭证”还是“脱证”,都是阳气聚集它处而不能归元的结果。所以,一般对于中风的治疗原则应该是先扶其真元,同时兼顾病邪的部位。真阳元气在哪里衰败,内邪外邪就会在哪里发生,若能恢复真元,内外两邪都能灭绝。由于中风分为“闭证”和“脱证”,“闭与脱,大不同”,风善行而数变,其所以变者,亦因人之脏腑寒热为转移。其人脏腑素有郁热,则风乘火势,火借风威,而风为热风矣。其人脏腑本属虚寒,则风水相遭,寒冰彻骨,而风为寒风矣。热风多见闭症,宜疏通为先;寒风多见脱症,宜温补为急。根据辨证施治的原则,很难对所有的中风患者用同一种药方进行治疗,如果对“闭证”和“脱证”不分型辩证,混淆用药,则会造成非常严重的医疗事故。
中风“闭证”以牙关紧闭,两手握固,痰壅气塞,或昏迷不省,身热肢厥为特征,多属中风或热病邪入营血内闭所致。《证治汇补》:“闭者,邪气闭塞于外,元气犹然在内,但与开关利气,则邪自散。”中风“闭证”型患者宜用开窍通络,清火豁痰之剂。部分中风病人留有后遗症,如偏瘫、失语等,这与病情轻重,治疗和护理是否及时得当有关,故急需有效的药物对中风“闭证”患者进行有针对性的治疗。
发明内容
本发明为了解决上述不足,提供一种治疗“闭证”型中风的中药组合物。
本发明解决上述问题所采用的技术方案是:一种治疗“闭证”型中风的药物组合物,其特征在于所述药物组合物由以下重量份组分组成:人参8~10份、当归2~3份、熟地2~3份、甘草10~12份、桂枝8~10份、麻黄提取物8~10份、石膏0.1~0.3份、桃仁4~5份、杏仁4~5份、黄连4~5、黄芩4~5份、大枣1~3份、干姜1~3份、牛黄4份~5份、苏合香1份~3份、安息香1份~3份、牛角4份~5份、龙骨1份~3份、牡蛎4份~5份、冰片0.1份~0.3份、石菖蒲1份~3份、琥珀0.1份~0.3份。
方中各组分的作用是:
人参甘温大补元气;附子大辛大热,温壮元阳。方中麻黄、桃仁、杏仁、生姜开表泄闭,疏通经络而驱风邪外出,人参、甘草、当归、熟地、桂枝益气温阳以扶正,石膏、大枣调气血,有助正气恢复;并取苦寒之黄芩、黄连,一以清泄风邪外望、里气不宣所产生之郁热,一以缓方中诸药之过于温燥;共成祛风扶正、温经通络之剂。牛黄、苏合香、安息香、冰片、琥珀能够通窍开闭、苏醒神识,特征用于“闭证”型中风;牛角、龙骨、牡蛎能够镇定浮阳、消除开窍药物的副作用,同时能够稳定病人情绪。
根据本发明的又一发明目的,本发明提供了一种治疗“闭证”型中风的药物组合物的制作方法,包括以下步骤:
(1)甘草、桂枝、黄连、黄芩、大枣、干姜、当归、熟地、牛角、龙骨、牡蛎、石菖蒲加水提取制备提取液。
(2)将(1)的提取液经过喷雾干燥器处理,得到提取物粉末。
(3)人参、石膏、杏仁、桃仁、麻黄提取物、牛黄、苏合香、安息香、冰片、琥珀粉碎后与步骤(2)中的提取物粉末混合得到药物组合物粉末。
(4)步骤(3)中的药物组合物粉末经过制粒得到所述的药物组合物制剂。
进一步的,一种治疗“闭证”型中风的药物组合物的制备方法,其特征在于:所述步骤(1)中,所述甘草、桂枝、黄连、黄芩、大枣、干姜、当归、熟地、牛角、龙骨、牡蛎、石菖蒲加8~10倍量水在70~80℃条件下提取2次,每次3~4小时。
进一步的,一种治疗“闭证”型中风的药物组合物的制备方法,其特征在于:所述步骤(2)中,所述喷雾干燥器的工作条件是:进风温度160~180℃、出风温度60~80℃、莫诺泵变频器频率10~15Hz、雾化器频率50Hz。
进一步的,一种治疗“闭证”型中风的药物组合物的制备方法,其特征在于:所述步骤(3)中,所述人参、石膏、杏仁、桃仁、麻黄提取物、牛黄、苏合香、安息香、冰片、琥珀用超微粉碎机粉碎至粒径20μm以下。
进一步的,一种治疗“闭证”型中风的药物组合物的制备方法,其特征在于:所述步骤(4)中,加入细粉量15~20%的70~80%乙醇,以60~80℃的温度烘1~2小时。
进一步的,一种治疗“闭证”型中风的药物组合物,所制备的剂型为胶囊剂或片剂或颗粒剂。
本发明的优点是:
本发明公开的一种治疗“闭证”型中风的中药组合物,在古方“续命汤”、“三化汤”的基础上增减修改,使药效更加专一地对“闭证”型中风起作用。综合现代制药方式,采用人参、石膏、杏仁、桃仁、麻黄提取物超微粉碎直接入药,使药物疗效加强,药物提取后的提取液经过喷雾干燥器处理,缩短了制备时间。
具体实施方式
以下给出本发明的具体实施例,用来对本发明作进一步详细说明。
下述实施例中的实验方法,如无特殊说明,均为常规方法。下述实施例中所用的药材原料、试剂材料等,如无特殊说明,均为市售购买产品。
实施例1
一种治疗“闭证”型中风的药物组合物的胶囊剂
按下述重量称取原料药(单位:Kg)
人参8、当归2、熟地2、甘草10、桂枝8、麻黄提取物8、石膏0.1、杏仁4、黄芩4、桃仁4、黄连4、黄芩4、大枣1、干姜1、牛黄4、苏合香1、安息香1、牛角4、龙骨1、牡蛎4、冰片0.1、石菖蒲1、琥珀0.1。
制备方法:
(1)甘草、桂枝、黄连、黄芩、大枣、干姜、当归、熟地、牛角、龙骨、牡蛎、石菖蒲加水336kg提取2次,每次3小时,过滤,合并滤液。
(2)将(1)的提取液经过进风温度160℃、出风温度60℃、莫诺泵变频器频率10Hz、雾化器频率50Hz的喷雾干燥器处理,得到提取物粉末6.3kg。
(3)人参、石膏、杏仁、桃仁、麻黄提取物、牛黄、苏合香、安息香、冰片、琥珀经过超微粉碎至粒径20μm以下,与步骤(2)中的提取物粉末混合得到药物组合物粉末36.6kg。
(4)在药物组合物粉末中加入5.5kg的70%乙醇,拌匀后以60℃的温度烘1小时。
(5)将药粉混合物粉末经过制粒机装胶囊处理,每粒装胶囊400mg,得到胶囊91500粒。
实施例2
一种治疗“闭证”型中风的药物组合物的片剂
按下述重量称取原料药(单位:Kg)
人参9、当归2.5、熟地2.5、甘草11、桂枝9、麻黄提取物9、石膏0.2、杏仁4.5、桃仁4.5、黄连4.5、黄芩4.5、大枣2、干姜2、牛黄4.5、苏合香2、安息香2、牛角4.5、龙骨2、牡蛎4.5、冰片0.2、石菖蒲2、琥珀0.2。
制备方法:
(1)甘草、桂枝、黄连、黄芩、大枣、干姜、当归、熟地、牛角、龙骨、牡蛎、石菖蒲510kg提取2次,每次4小时,过滤,合并滤液。
(2)将(1)的提取液经过进风温度180℃、出风温度80℃、莫诺泵变频器频率15Hz、雾化器频率50Hz的喷雾干燥器处理,得到提取物粉末7.65kg。
(3)人参、石膏、杏仁、桃仁、麻黄提取物、牛黄、苏合香、安息香、冰片、琥珀经过超微粉碎至粒径20μm以下,与步骤(2)中的提取物粉末混合得到药物组合物粉末43.75kg。
(4)加入75%乙醇7.66kg,以70℃的温度烘1.5小时。
(5)将药粉混合物粉末经过压片机压片处理,每片400mg,得到药品109375片。
实施例3
一种治疗“闭证”型中风的药物组合物的颗粒剂
按下述重量称取原料药(单位:Kg)
人参10、当归3、熟地3、甘草12、桂枝10、麻黄提取物10、石膏0.3、杏仁5、桃仁5、黄连5、黄芩5、大枣3、干姜3、牛黄5、苏合香3、安息香3、牛角5、龙骨3、牡蛎5、冰片0.3、石菖蒲3、琥珀0.3。
制备方法:
(1)甘草、桂枝、黄连、黄芩、大枣、干姜、当归、熟地、牛角、龙骨、牡蛎、石菖蒲加水600kg提取2次,每次3.5小时,过滤,合并滤液。
(2)将(1)的提取液经过进风温度170℃、出风温度70℃、莫诺泵变频器频率13Hz、雾化器频率50Hz的喷雾干燥器处理,得到提取物粉末9.1kg。
(3)人参、石膏、杏仁、桃仁、麻黄提取物、牛黄、苏合香、安息香、冰片、琥珀经过超微粉碎至粒径20μm以下,与步骤(2)中的提取物粉末混合得到药物组合物粉末51kg。
(4)将步骤(3)得到的药物组合物粉末中按药粉:淀粉:蔗糖=3:1:1的比例加入淀粉17kg、蔗糖17kg,混合均匀,加入80%乙醇17kg,以80℃的温度烘2小时。
(5)将干燥后的药物干燥,整粒,装袋,每袋4g,共得21250袋。
实施例4
一种治疗“闭证”型中风的药物组合物的应用
一种治疗“闭证”型中风的药物组合物,特定针对“闭证”型中风使用。
实验例1
本发明的中药组合物的动物急性毒性试验
本实施例通过小鼠口服给药药物半数致死量的测定,考察了实施例2制备的中药组合物对小鼠的急性毒性反应和死亡情况。
取小鼠30只,每组10只,分3组,即高、中、低3个剂量组(0.8、0.4、0.2ml/15g)灌胃给药3次/日,预测药物半数致死量的范围。结果显示,高剂量组测不出半数致死量,故将药物灌胃给药半数致死量的测定改做最大体积下之最大弄点—最大耐受量的测定。
取小鼠30只,空腹12小时后,以预测选定的0.8ml/15g计量逐只灌胃给药给受试动物3次/日,连续观察7天。
在灌胃给受试品24小时,小鼠自发性活动下降,摄食、摄水减少;第二天自发性活动逐渐趋于正常,大、小便未见异常,小鼠活动、摄食量、体重增长、粪便等均正常,观察期满后受试小鼠全部存活。
观察期满后处死全部受试小鼠肉眼尸检,发现各重要脏器,如心、肝、脾、肺、肾、卵巢、肠、胃等无明显病理形态改变。
药物灌胃给药的最大给药量试验结果表明:30只小鼠给药后均无明显的毒性反应,一周内亦无死亡。给小鼠灌胃给药药物后测得最大耐受量为47.1g/kg·d,如按临床成人口服剂量8.0g/60kg计算,则该药的小鼠一日灌胃最大耐受量为临床成人一日口服量的[(47.1g/kg)÷(8.0g/60kg)≈353]倍。说明本发明所述中药组合物的安全性好。
实验例2
本发明一种治疗“闭证”型中风的中药组合物的人体试验
临床资料
一、一般性资料:本中药组合物应用于临床观察病例100例,男67例,女33例,年龄30~70岁。
二、用法用量:临床应用时,组合物中的组分根据患者的体重、年龄及症状酌情增减。本发明实施例1药物,一次三粒,一日三次。服药期间低盐、低脂饮食,禁烟酒。
三、疗效标准:
(1)痊愈:临床症状消失,生活完全自理,并能从事劳动;
(2)显效:临床症状和体征基本消失,生活可自理;
(3)有效:症状和体征一部分好转;
(4)无效;症状和体征均无明显改善,症状如前。
四、治疗效果:该临床观察病例中,服药1~6个月,治疗期间未发生毒副作用,具体情况见下表1。
表1本发明专利的产品在临床应用中的治愈情况
总之,本发明所述的一种治疗“闭证”型中风的中药组合物,为纯中药制剂,药方精简,制备方法简单、加工成本低、疗效显著、无任何不良反应,药力强、见效快,能迅速消除“闭证”型中风症状,采用现代工艺制药,方便服用的特点。
以上仅为本发明的优选实施例而已,并不用于限制本发明,对于本领域的技术人员来说,本发明可以有各种更改和变化。凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
Claims (8)
1.一种治疗“闭证”型中风的药物组合物,其特征在于,所述药物组合物由以下质量份组分组成:人参8份~10份、当归2份~3份、熟地2份~3份、甘草10份~12份、桂枝8份~10份、麻黄提取物8份~10份、石膏0.1份~0.3份、桃仁4份~5份、杏仁4份~5份、黄连4份~5份、黄芩4份~5份、大枣1份~3份、干姜1份~3份、牛黄4份~5份、苏合香1份~3份、安息香1份~3份、牛角4份~5份、龙骨1份~3份、牡蛎4份~5份、冰片0.1份~0.3份、石菖蒲1份~3份、琥珀0.1份~0.3份。
2.一种如权利要求1所述的药物组合物的制备方法,包括以下步骤:
步骤S01、甘草10份~12份、桂枝8份~10份、黄连4份~5份、黄芩4份~5份、大枣1份~3份、干姜1份~3份、当归2份~3份、熟地2份~3份、牛角4份~5份、龙骨1份~3份、牡蛎4份~5份、石菖蒲1份~3份加水提取制备提取液。
步骤S02、将步骤S01的提取液经过喷雾干燥器处理,得到提取物粉末。
步骤S03、将人参8份~10份、麻黄提取物8份~10份、石膏0.1份~0.3份、桃仁4份~5份、杏仁4份~5份、牛黄4份~5份、苏合香1份~3份、安息香1份~3份、冰片0.1份~0.3份、琥珀0.1份~0.3份经过超微粉碎,与步骤S02中的提取物粉末混合得到药物组合物粉末。
步骤S04、步骤S03中的药物组合物粉末经过制粒得到所述的药物组合物制剂。
3.根据权利要求2所述的制备方法,其特征在于,步骤S01中,所述加水提取制备提取液为:加甘草、桂枝、黄连、黄芩、大枣、干姜、当归、熟地、牛角、龙骨、牡蛎、石菖蒲总重量8倍~10倍量水在70℃~80℃条件下提取2次,每次3小时~4小时。
4.根据权利要求2所述的制备方法,其特征在于,步骤S02中,所述喷雾干燥器处理为:喷雾干燥器的进风温度160℃~180℃、出风温度60℃~80℃、莫诺泵变频器频率10Hz~15Hz、雾化器频率50Hz。
5.根据权利要求2所述的制备方法,其特征在于,步骤S03中,所述超微粉碎为:将人参、石膏、杏仁、桃仁、麻黄提取物、牛黄、苏合香、安息香、冰片、琥珀用超微粉碎机粉碎至粒径20μm以下。
6.根据权利要求2所述的的制备方法,其特征在于:所述步骤S04中,所述制粒为:加入药粉量15%~20%的70%~80%乙醇,以60℃~80℃的温度烘1小时~2小时。
7.根据权利要求2所述的制备方法,其特征在于,所述的药物组合物制剂为胶囊剂/片剂/颗粒剂。
8.一种治疗“闭证”型中风的药物组合物的应用,其特征在于,所述的药物组合物,特定针对“闭证”型中风使用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610474229.8A CN105879001A (zh) | 2016-06-23 | 2016-06-23 | 一种治疗“闭证”型中风的药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610474229.8A CN105879001A (zh) | 2016-06-23 | 2016-06-23 | 一种治疗“闭证”型中风的药物组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105879001A true CN105879001A (zh) | 2016-08-24 |
Family
ID=56719008
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610474229.8A Withdrawn CN105879001A (zh) | 2016-06-23 | 2016-06-23 | 一种治疗“闭证”型中风的药物组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105879001A (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1539447A (zh) * | 2003-04-27 | 2004-10-27 | 王振廷 | 治疗中风先兆症、中风后遗症、胸痹的复康药酒及制备方法 |
CN101401927A (zh) * | 2008-11-14 | 2009-04-08 | 唐光红 | 用于治疗中风的中药散剂 |
CN103933200A (zh) * | 2014-01-14 | 2014-07-23 | 李承文 | 一种治疗中风后遗症的中药组合物 |
CN105012855A (zh) * | 2014-04-23 | 2015-11-04 | 天津药物研究院 | 一种用于治疗中风的药物组合物及其制备方法和应用 |
CN105687707A (zh) * | 2016-02-02 | 2016-06-22 | 泉州市惠安闽投商贸有限公司 | 一种治疗“脱证”型中风的药物组合物 |
-
2016
- 2016-06-23 CN CN201610474229.8A patent/CN105879001A/zh not_active Withdrawn
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1539447A (zh) * | 2003-04-27 | 2004-10-27 | 王振廷 | 治疗中风先兆症、中风后遗症、胸痹的复康药酒及制备方法 |
CN101401927A (zh) * | 2008-11-14 | 2009-04-08 | 唐光红 | 用于治疗中风的中药散剂 |
CN103933200A (zh) * | 2014-01-14 | 2014-07-23 | 李承文 | 一种治疗中风后遗症的中药组合物 |
CN105012855A (zh) * | 2014-04-23 | 2015-11-04 | 天津药物研究院 | 一种用于治疗中风的药物组合物及其制备方法和应用 |
CN105687707A (zh) * | 2016-02-02 | 2016-06-22 | 泉州市惠安闽投商贸有限公司 | 一种治疗“脱证”型中风的药物组合物 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101632827B (zh) | 一种治疗银屑病的中药组合物及其制备方法 | |
CN101822704B (zh) | 一种祛斑药物组合物及其制备方法 | |
CN105920514A (zh) | 治疗代谢综合征的中药组合物 | |
CN102293927B (zh) | 具有抗疲劳和抗氧化功能的复方中药制剂及其制备方法 | |
CN102258680B (zh) | 一种缓解体力疲劳的中药组合物及其制备方法和应用 | |
CN102106965B (zh) | 一种治疗软组织急性损伤的组合物及其应用 | |
CN100421699C (zh) | 一种治疗男性不育生精复方中药制剂 | |
CN104436145B (zh) | 一种预防和/或治疗过敏性鼻炎及过敏性哮喘的药物组合物 | |
CN102861283A (zh) | 一种用于治疗癫痫病的药物组合物及其制备方法和用途 | |
CN102416144A (zh) | 治疗小儿惊风的中药 | |
CN102139081B (zh) | 一种治疗复发性口腔溃疡中药组合物、制剂及其制备方法 | |
CN102552537B (zh) | 一种用于治疗气血亏损的中药组合物 | |
CN102293985B (zh) | 用于治疗冠心病的中药组合物及其制备方法 | |
CN105879001A (zh) | 一种治疗“闭证”型中风的药物组合物 | |
CN105687707A (zh) | 一种治疗“脱证”型中风的药物组合物 | |
CN101816708B (zh) | 治疗风湿病的中药组合物及其制备方法 | |
CN105688110A (zh) | 一种阿胶补血养颜口服液及其生产方法 | |
CN103877513A (zh) | 一种具有降血脂功效的中药复方组合物及其应用 | |
CN109464565A (zh) | 一种治疗胸痹心痛的中药组合物及其制剂 | |
CN105878742A (zh) | 一种益胃中药组合物 | |
CN111888448B (zh) | 一种治疗银屑病的中药组合物 | |
CN102631496B (zh) | 提高免疫力、抗疲劳的中药组合物 | |
CN102743499A (zh) | 中草药治疗软组织内伤瘀血和脑出血的药物及其制备方法 | |
CN102302655A (zh) | 枇杷清痤胶囊 | |
CN106668787A (zh) | 治疗肝坏死、肝癌的中药蜜丸及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160824 |
|
WW01 | Invention patent application withdrawn after publication |